How are we doing?
How can we help you?
AllCells
AllCells
Home » News & Events

AllCells News & Events

The AllCells News & Events page includes all of the latest Press Releases, Announcements, Media Information, and Event Information. Throughout the year we will continue to update this page with the most relevant AllCells News & Events. Check back often or stay up-to-date with announcements through our exclusive eNewsletter. Sign-up today! Show more information

For more details about News & Events please click to expand each entry.
2014-11-19
AllCells proudly exhibiting at 56th Annual ASH Meeting in San Francisco, CA Dec 6-9
Join AllCells at the ASH 56th Annual Meeting taking place December 6-9th 2014 in our backyard of San Francisco, CA. Visit us at Booth #508 and meet with our scientists who will be featuring new products & bioservices. For more information click here....
2014-10-21
Join AllCells at the AABB 2014 Annual Meeting in Philadelphia, PA Oct 25-28
AllCells will be exhibiting at the American Association of Blood Banks Annual Meeting taking place this year in Philadelphia, PA between October 25-28th 2014. Please visit us at Booth #1012 to learn more about how we can accelerate your research and serve as your...
2014-06-09
Exhibiting at 12th Annual ISSCR Meeting Vancouver, BC 6/18-6/21
We will be exhibiting at booth #807 at the upcoming 12th Annual International Society for Stem Cell Research meeting taking place in Vancouver, BC. AllCells will be the official sponsor of the Chinese Stem Cell Foundation reception held during the meeting. More...
2014-05-02
AllCells to Participate in Partnering Business Forum at 2014 BIO International Convention - San Diego, CA
ALAMEDA, California – May 2, 2014 – AllCells, a leading provider of healthy & diseased hematological tissue, primary cell-based products, and Bioservices will be attending the 2014 Biotechnology Industry Organization (BIO) International Convention...
2014-04-28
Exhibiting at PEGS Summit Boston 5/5-5/9
AllCells will be exhibiting at booth #204 at the upcoming 10th Annual Protein Engineering Summit in Boston, MA. Attendees will have a chance to visit with our scientists and learn how we can help accelerate your research! More information about the summit here....
2014-04-22
AllCells is proudly sponsoring Immunology 2014
AllCells is proud to be a sponsor for the upcoming American Association of Immunologists annual meeting, Immunology 2014, taking place in Pittsburgh, PA between May 2-6. The company will be exhibiting new products and bioservices at Booth #607. Please stop by...
2014-04-14
Cellular Dynamics agreement paves way for iPSC biobank creation
Today AllCells announced its new agreement with Cellular Dynamics to process peripheral blood for the production of iPSCs. Please read the full news release on our Blog for more information.
2014-03-10
Exhibiting at AACR April 6-9, San Diego, CA
AllCells will be exhibiting alongside other leading cancer research biotech organizations at the AACR (American Association for Cancer Research) Annual Meeting taking place April 6-9th in San Diego. Visit Booth #922 to meet with our representatives...
2013-11-25
Proud sponsor of the 6th Annual Maryland Stem Cell Research Symposium at Johns Hopkins Tuesday, Dec 3rd
The 6th Annual Maryland Stem Cell Research Symposium will feature AllCells as an exhibiting sponsor on Tuesday, December 3rd at Johns Hopkins Medical Center. Engage in comprehensive scientific talks, poster presentations, Ethics discussions and networking with...
2013-11-14
Join AllCells at the 55th Annual ASH Meeting in New Orleans, LA Dec 6-11
AllCells is proud to be exhibiting at the American Society of Hematology 55th Annual Meeting in New Orleans, Louisiana between December 6-11th 2013. Please visit us at Booth #3931. Meeting information here....
2013-05-29
Exhibiting at ISSCR Annual Meeting - Boston, MA, June 12-15
Join AllCells at the International Society for Stem Cell Research 11th Annual Meeting taking place June 12-15th 2013 in Boston, MA. Visit us at Booth #600 and meet with associates as we feature our new bioservices for 2013 and win a chance at a prize! For more...
2013-04-30
Exhibiting at AAI Immunology 2013 - Honolulu, HI, May 3-7
Join AllCells at the 100th Anniversary of Immunology 2013, American Association of Immunologists Annual Meeting. Visit us at Booth #1409 and meet with associates as we unveil our new products/services for 2013 and win a chance at a prize! For more information...
2013-04-24
Visit AllCells at the upcoming 9th Annual Protein and Antibody Engineering Summit in Boston 4/29-5/3
AllCells will be exhibiting at the 9th Annual Protein and Antibody Engineering Summit (PEGS) taking place in Boston, MA 4/29-5/3. Join us and other leading biotechnology companies, learn about our new bioservices....
2013-04-17
AllCells to Participate in Partnering Business Forum at 2013 BIO International Convention - Chicago, IL
ALAMEDA, California – April 17, 2013 – AllCells, a leading provider of healthy & diseased hematological tissue, primary cell-based products, and Bioservices will be attending the 2013 Biotechnology Industry Organization (BIO) International Convention...
2013-03-27
Exhibiting at AACR April 6-10, Washington DC
AllCells will be joining other leading cancer research biotech organizations at the AACR (American Association for Cancer Research) Annual Meeting taking place April 6-10th in Washington DC. Visit Booth #1705 to meet with our associates and...
2013-03-04
AllCells office will be moving to Alameda, CA
AllCells will be moving to an expanded facility located in Alameda, CA, just south of our current Emeryville location during the last two weeks in March. The 30,000 square feet of lab/office space will add 70% more operational space which will enable us to better...
2013-02-21
AllCells Launches Bioservices Pages
AllCells has launched our Bioservices homepage to complement our new division featuring immunoassays, stem cell assays, flow cytometry services, tissue culture services, protein analysis, and genotyping.
To read more on our blog: 
2013-01-22
Exhibiting at the Molecular Med Tri-Con 2013
Please join us in San Francisco at the Molecular Med Tri-Con February 11-15th. Visit Booth #503 to meet with AllCells associates as we debut our new products/services for 2013! For more information see the official website for the conference here....
2013-01-03
Introducing AllCells Bioservices
Today AllCells announced its new Bioservices launch. Please read the full news release on our Bioservices line for more information.
2012-12-13
AllCells Announces Plans to Relocate and Expand U.S Operations
Today AllCells announced plans to relocate its U.S operations to Alameda, California. The relocation will occur towards the end of Q1, 2013. Please read the full news release here.
2012-12-07
We invite you to join us at the upcoming ASCB Meeting in San Francisco, Dec 16-18
Join us in our backyard as San Francisco hosts the 2012 American Society for Cell Biology Annual Meeting. Visit Booth #1204 to meet several AllCells associates as we debut our new products/services for 2013 and win a chance at a prize! For more information see the official website for the conference here.
2012-11-30
Official sponsor of ASH Annual Meeting 2012, join AllCells in Atlanta, GA Dec 8-11
AllCells is proud to be exhibiting at the American Society of Hematology 54th Annual Meeting in Atlanta, Georgia between December 8-11th 2012. We will be supporting the Abstract Achievement Awards for the 2nd consecutive year, enabling young researchers to present their work at the meeting. Please visit us at Booth #2705. Meeting information here.
2012-11-20
AllCells Enters into Distribution Agreement with Wako Pure Chemical Industries in Japan
(EMERYVILLE, CA) November 20, 2012 - AllCells, LLC a leading global provider of human hematologic tissue, healthy & diseased primary cells, and cell-based assay services, today announced it has entered into a Distribution Agreement with Wako Pure Chemical Industries, Ltd. (Osaka, Japan), a leading global provider of laboratory chemicals, specialty chemicals, and diagnostic reagents. Under the agreement AllCells has granted Wako Pure Chemical Industries non-exclusive rights to distribute its products to Japan’s life science research community. Dr. Elaine Horibe Song, Senior Product Manager indicated “We are pleased to partner with Wako to provide researchers with access to more than 600 products and relevant clinical data from healthy and diseased hematologic tissue, such as bone marrow, peripheral blood, Leukopaks, and cord blood.” Dr. Jack Zhai, VP of Sales & Marketing added, “Wako’s large commercial network of direct sales, sub-dealers, and substantial ecommerce capabilities provides AllCells with greater access to a large number of end users including scientists within the academia/non-profit market segment.” AllCells’ President and Chief Executive, Jay Tong, M.D commented, “Japan’s drug discovery and pre-clinical development market are key application areas for AllCells’ products and services. Wako’s well-established market presence, broad selection of high quality laboratory chemicals and reagents, and comprehensive sales channels enhance our ability to better serve the needs of scientific researchers in Japan”. About AllCells, LLC AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells (healthy & diseased) which enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications in which in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce the time needed to isolate cells with guaranteed consistency, thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements. AllCells, LLC Media Contact: Wayne E. Vaz, 603 490 7992 Vice President, Corporate & Business Development wvaz@allcells.com
2012-09-10
AllCells Introduces Autoimmune Diseased Cells and Tissue Products
AllCells, LLC, a leading provider of healthy & diseased hematopoietic tissues, primary cell types, and related services to the global life science industry has announced the release of new autoimmune diseased cells and tissue products. The specimens may be used in preclinical research, drug discovery, drug toxicity, diagnostic related assays, and other life science research applications. All products are indicated for in vitro research use only. Read more on Autoimmune Diseased Cells and Tissue Products.
2012-08-22
AllCells, LLC Named to Inc. Magazine's 500/5000 List of Fastest Growing Companies
Leading Provider of Hematology-Based Products & Services to the Life Science Industry Ranked No. 2,420 of Fastest Growing Private Companies in U.S. Please read the full news release here.
2012-06-06
AllCells, LLC Named Winner of 'Fast 50' Asian American Business Award for Second Consecutive Year
Emeryville, CA – June 06, 2012 – AllCells, LLC, a leading global provider of healthy & diseased hematopoietic tissues, primary cell types, and related services has been ranked for a second consecutive year among Fast 50 Asian American Businesses 2012 by the Washington DC-based US Pan Asian American Chamber of Commerce Education Foundation (USPAACC). The Fast 50 Asian American Business Awards were presented June 5, 2012 at the Marriott Bethesda North Hotel & Conference Center in Bethesda, MD at USPAACC’s Annual Excellence Awards Reception and Gala. Wayne Vaz, VP Corporate & Business Development, accepted the award on behalf of AllCells. To qualify for the ranking companies must be owned by one or more Asian Americans (at least 51% ownership) among other eligibility criteria. Through direct application and nomination, selection is determined and based on percentage revenue growth over the past 3 years along with other eligibility criteria. Finalists are independently verified by a renowned accounting firm. “It’s wonderful for AllCells to be recognized by USPAACC for a second year in a row as a Fast 50 company”, said Jay Tong, MD, the company’s President & CEO. “We’re extremely grateful for the trust and confidence our customers have shown us in choosing our products to enable their cell-based research studies. Of course, I’m immensely proud of AllCells’ team for the high level of commitment each individual continues to demonstrate towards ensuring high quality products and service excellence are delivered to our valued customers every day”, added Dr. Tong. The USPAACC is the oldest and largest national, nonprofit, non partisan organization representing all Asian American and Asian American related groups in business, sciences, the arts, sports, education, public and community services. About AllCells, LLC AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements. For more information, direct inquiries to: Contact: Wayne Vaz, VP, Corporate Development P 603 490 7992
2012-06-01
AllCells to Participate in Partnering Business Forum at 2012 BIO International Convention - Boston, MA
EMERYVILLE, California – June 1, 2012 – AllCells, a leading provider of healthy & diseased hematological tissue, primary cell-based products, and services will be attending the 2012 Biotechnology Industry Organization (BIO) International Convention One-on-One Partnering™ program to be held Jun 18-21 in Boston, MA. Wayne Vaz – VP, Corporate & Business Development, Jack Zhai - VP, Marketing & Sales, and Elaine Horibe Song - Sr. Product Manager, will be available to meet at the Boston Convention & Exhibition Center to discuss the company’s capabilities, strategic partnership and collaboration interests. According to BIO, One-on-One Partnering™ has grown over the past 11 years to become biotech’s largest partnering event, hosting a record breaking 21,000+ partnering meetings in 2011. This year BIO estimates that 4,000 companies will be participating in the One-on-One Partnering™ System including delegates from 65 countries with 25,000 meetings expected over 4 days. BIO Business Forum participants interested in learning more about AllCells or scheduling meetings to discuss partnering opportunities should log into BIO’s One-on-One Partnering™ program page at http://oneononepartnering.bio.org/BusinessForum2012/. Individuals not directly participating in the Business Forum who wish to meet AllCells company representatives may contact Wayne Vaz at wvaz@allcells.com to arrange an alternative meeting venue. BIO One-on-One Partnering is a trademark of the Biotechnology Industry Organization About AllCells, LLC AllCells (www.allcells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease, and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements.
2012-05-29
Upcoming International Exhibition: ISSCR 2012 Annual Meeting, June 13-16 in Yokohama, Japan
AllCells is proud to be exhibiting at the International Society for Stem Cell Research 10th Annual Meeting in Yokohama, Japan between June 13-16th 2012. This will be an excellent opportunity to meet with us in Asia. Please visit us at Booth #400. Meeting info here.
2012-05-02
Official sponsor of Immunology 2012, join AllCells in Boston, MA this week, May 4-8
AllCells is proud to sponsor this year's American Association of Immunologists Annual Meeting. Visit our booth #204 to meet with several representatives about your research. For more information see the official website for the conference here.
2012-04-23
Visit AllCells at the PEGS Summit in Boston, MA next week, Apr 29 - May 1
We will be exhibiting at booth #27 at the upcoming 8th Annual Protein Engineering Summit in Boston. Come see us, speak with us about your research, and earn a chance to win a brand new kindle fire! More info about the summit here.
2012-03-15
AllCells to exhibit at AACR Annual Meeting, Mar 31 - Apr 4 in Chicago, IL
Visit AllCells booth #1501 at the upcoming American Association for Cancer Research meeting in Chicago. Tell us about your research and win prizes! More info about the meeting here.
2012-03-01
Join AllCells at the 2012 ToxExpo - March 11-15, San Francisco, CA
AllCells will be exhibiting at the Society of Toxicology ToxExpo 2012 in San Francisco, CA from March 11-15. Stop by and say hello at Booth #2008. More info here.
2012-02-03
AllCells, WiCell, and WARF Enter into Biomaterials License Agreement
(EMERYVILLE, CA) February 3, 2012 - AllCells, LLC a global provider of human primary cells and related services, announced it has entered into a biomaterials license agreement with the WiCell Research Institute and Wisconsin Alumni Research Foundation (WARF). The agreement allows AllCells to cultivate the pluripotent cell lines derived from hematopoietic cancer cells obtained by the company. Under the agreement WiCell will distribute the pluripotent cell lines to stem cell researchers and WARF’s non-exclusive license allows AllCells to use the pluripotent cell lines for non-commercial research purposes. The pluripotent lines were developed by Dr. Igor Slukvin and his research team at the University of Wisconsin-Madison. “Induced pluripotent stem cell (iPSC) lines are emerging as an important platform technology for deriving specific biological cell types that would otherwise be difficult to source. These iPSC-derived cell types offer great potential for use as an enabling research tool for pre-clinical drug development,” said Dr. Jack Zhai, Vice President Marketing and Sales at AllCells and an alumnus of the University of Wisconsin-Madison. “AllCells supports WiCell’s goal of making these cell lines available as a tool for advancing scientific research. We will continue to look for opportunities to establish license, product and service supply agreements with leading life science companies.” “We are excited to add these new iPS cell lines to WiCell’s growing list of cell lines available through our Wisconsin International Stem Cell (WISC) Bank,” said Erik Forsberg, Ph.D., executive director of WiCell. “We look forward to working with AllCells and other organizations to offer pluripotent stem cell lines for research and clinical development.” About AllCells, LLC AllCells (www.allcells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications in which in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce the time needed to isolate cells with guaranteed consistency, thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements. About WiCell WiCell Research Institute is a Wisconsin nonprofit organization that was established in 1999 to advance stem cell research and development. WiCell distributes pluripotent stem cell lines through the Wisconsin International Stem Cell (WISC) Bank and provides comprehensive cytogenetic services (including karyotyping, FastFISH™ and array-based comparative genomic hybridization (aCGH)). WiCell also offers Quality Control testing services and clinical grade pluripotent cell lines to researchers worldwide. About WARF Since its founding in 1925 to manage a UW–Madison discovery that eventually eliminated the childhood disease rickets, WARF has been working with industry to transform university research into products that benefit society. As a private, nonprofit organization, WARF accomplishes its mission of supporting scientific research by patenting and licensing inventions arising from university discoveries. Since making its first grant of $1,200 in 1928, WARF has contributed more than $1 billion to UW–Madison through annual "margin of excellence'' grants and other funding. For more information, visit www.warf.org. AllCells, LLC Media Contact: Wayne E. Vaz, 603 490 7992 Vice President, Corporate & Business Development wvaz@allcells.com
2012-02-01
AllCells to present at upcoming 7th Annual New York Stem Cell Summit
For the second year in a row, AllCells will be speaking at the 7th Annual New York Stem Cell Summit taking place in New York City on February 21st. More information about the summit can be found here.
2012-01-03
AllCells Granted Biologics License
Emeryville, CA (January 3, 2012) – AllCells, LLC announced that it has been granted a License for the Production of Biologics by the State of California Department of Public Health in accordance with Division 2, Chapter of the Health and Safety Code. This license enables AllCells to engage in broader business development opportunities involving the collection, processing, storage, or distribution of human hematological tissue and tissue derivatives. Together with the previously granted Tissue Bank License AllCells complies with laws and regulations covering the supply of products that support drug discovery, stem cell research, cell-based assay development, and a multitude of other important life science industry applications. AllCells is committed to providing its customers with high quality biological products and services in an ethical manner according to IRB-approved protocols, and in compliance with current government regulations. About AllCells, LLC AllCells (www.allcells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements. AllCells, LLC Media Contact: Wayne E. Vaz, 603 490 7992 Vice President, Corporate & Business Development wvaz@allcells.com
2011-12-30
Upcoming Exhibition - PepTalk 2012 The Protein Science Week
AllCells will be exhibiting at PepTalk 2012 in Coronado, CA from January 9-11. More information about the conference can be found here.
2011-12-05
AllCells, LLC Forms Scientific Advisory Board

EMERYVILLE, Calif.--(BUSINESS WIRE)-- AllCells, LLC, a leading global provider of hematology and immunology based primary cells and related services for drug discovery, toxicology, stem cell research, and other life science applications today announced the appointment of its first Scientific Advisory Board (SAB). The new SAB members include: Linzhao Cheng, PhD - Professor of Medicine and a founding member of the Stem Cell Program in the Johns Hopkins Institute for Cell Engineering, JHU School of Medicine (JHUSOM), Baltimore, MD. He is also the Associate Director for Basic Research, Division of Hematology, and a faculty member in PhD Training Programs in Cellular & Molecular Medicine, Human Genetics and Immunology in JHUSOM. Dr. Cheng will serve as Chairman of AllCells’ SAB. Ronald Hoffman, MD - Professor of Medicine at the Mount Sinai School of Medicine, New York, NY, Co-Director, Myeloid Malignancy Program (MPP) of the Tisch Cancer Institute (TCI), Mount Sinai School of Medicine, Principal Investigator of the Myeloproliferative Research Consortium (MPD-RC) - a program project grant funded by the NCI, and a former President of the American Society of Hematology. Timothy C. Fong, PhD, MBA - Vice President, Technology and Product Development at Progenitor Cell Therapy (a NeoStem, Inc. company), Mountain View, CA. He is the former Technical Director, Cell Therapy, and Director of the BD Cell Therapy initiative at BD Biosciences, VP Research at Cellerant Therapeutics, and VP Discovery Research at Sangstat Medical Corp. AllCells’ President and Chief Executive, Jay Tong, MD, commented, “These outstanding scientific leaders together offer broad knowledge and expertise in the fields of hematology, immunology, cancer research, and stem cell science. Their contributions will be vitally important for shaping the future direction of AllCells’ products and services which serve the life science community.” “AllCells has experienced steady growth during the past several years and the newly created SAB is an important milestone in the company’s development. The SAB is expected to strengthen AllCells’ ability to identify and assess strategic opportunities that fit squarely with the company’s core competencies,” added Wayne Vaz, Vice President of Corporate Development. About AllCells, LLC AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements. .

Contacts

AllCells, LLC Wayne Vaz, 603-490-7992 Corporate & Business Development View full release
2011-11-21
ASH Exhibition - December 10-13, San Diego, CA
AllCells is proud to be exhibiting at the upcoming, 53rd Annual Meeting of the American Society of Hematology. Please come say hello at booth #616! Stop by to learm more about our products and services. Please visit the official conference website to learn more about this event here.
2011-10-31
Free webinar "Leuko Pak 101" to be hosted by AllCells on December 1st & 5th
AllCells will be broadcasting a free webinar on December 1st, 9:00am - 10:00am PST and again December 5th, 5:00pm - 6:00pm PST titled "Leuko Pak 101: How leukapheresis products are best utilized in the lab". Join our team as we discuss leukapheresis, our Leuko Pak product line, and various related research applications. Learn and exchange information about this under-utilized source of, amongst other things, large quantities of cells that typically have lower yields. >>Official registration December 1st here >>Official registration December 5th here
2011-09-01
AllCells, LLC Expands Operations in Shanghai, China

AllCells-Shanghai is now situated in Ju Ke Park (聚科生物园区) near the center of the city with almost 10,000 sq. ft of laboratory, production and office space. The new facility is also equipped with GMP level cell culture rooms. AllCells’ Chief Executive, Jay Tong, MD commented, “The Ju Ke Biotechnology Park location not only provides the larger space that is essential for supporting the company’s continuing growth, but also enables us have access to better and highly controlled bio-processing environments. This is a really important consideration for producing high quality primary cell products, tissues, and services that our customers depend upon for their biomedical applications.”

AllCells-Shanghai is currently recruiting individuals to fill several open positions in the areas of Sales & Marketing / Business Development, Production, and Operations Management. Refer to the Careers section of www.AllCells.com for more information.

About AllCells, LLC

AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements.

AllCells-Shanghai facilities produce animal derived primary cell types including bone marrow mononuclear cells, stromal cells, immunological, splenocytes, pancreatic islets, neural system (astrocytes, meningeal cells), and others. The company’s products are used in routine cell-based assays for compound screening, predictive toxicology, and other research applications that enable pre-clinical drug development. Additionally, the company plans to expand its service offering to include hematopoietic stem cell expansion & differentiation, flow-cytometry services (e.g. comprehensive FACS analysis, up to 11 colors), immunophenotyping, in-vitro characterization of malignant cells (e.g. leukemia, myeloma, lymphoma, etc.), custom cell-based assays, and validation studies involving cell/tissue separation devices for laboratory or clinical use by importing AllCells-USA made human primary cells.

Contacts

AllCells, LLC Wayne Vaz, 510-521-2600 Corporate & Business Development View full release
2011-08-26
Exhibit At Stem Cells In Drug Discovery And Development Conference - Nov 2-3
AllCells will be represented at the upcoming, highly-anticipated  Stem Cells in Drug Discovery and Development conference taking place from November 2-3 in San Diego, CA. Stop by our booth to learn more about our products and services.Please visit the official conference website to learn more about this exciting event!
2011-06-29
Certification As Small And Minority Owned Business
Emeryville, CA (June 29, 2011) – AllCells, LLC (the “company”) announced that it has been certified as both a Minority Owned Business Enterprise (MBE) and a Small Business (SB). The company has been granted MBE status by both the Northern California Minority Supplier District Council (NCMSDC) and The Supplier Clearinghouse. Additionally, AllCells is certified as a Small Business with the State of California Office of Small Business and DVBE Services. These certifications qualify AllCells to supply its products and services to organizations in the private sector or to government agencies throughout the United States who maintain supplier diversity initiatives and programs. For more information please contact us at info@allcells.com.
2011-06-01
AllCells Will Be Present At The 9th Annual ISSCR Meeting In Toronto, Cananda - June 15-18
We will be presenting our new innovative custom projects and services at the International Society for Stem Cell Research meeting on June 15-18. Please stop by booth #325 to learn more. For more information on ISSCR, please visit www.isscr.org
2011-04-19
AllCells, LLC Ranked Among The Top 50 Fastest Growing Asian-American Businesses
EMERYVILLE, Calif.--(BUSINESS WIRE)--AllCells, LLC, a leading global provider of human hematopoietic primary cells and related services has been ranked among the top 50 fastest growing Asian-American businesses by the Washington DC-based US Pan Asian American Chamber of Commerce Education Foundation (USPAACC). The excellence awards gala ceremony will take place on the evening of May 24, 2011 at the Millennium Biltmore Hotel in Los Angeles, CA. To qualify for the ranking companies must be owned by one or more Asian-Americans (at least 51% ownership) among other eligibility criteria. Through direct application and nomination, selection is determined and based on percentage revenue growth over the past 3 years along with other eligibility criteria. Finalists are independently verified by a renowned accounting firm. AllCells’ Chief Executive, Jay Tong, MD, commented “It’s truly an honor for AllCells to be recognized this year by the USPAACC as a top 50 fastest growing Asian-American business, especially in light of the challenging economic environment small businesses have faced in recent years. It’s really a testament to the hard work and dedication to service excellence our employees demonstrate towards our customers every single day.” The USPAACC is the oldest and largest national, nonprofit, nonpartisan organization representing all Asian-American and Asian-American related groups in business, sciences, the arts, sports, education, public and community services. About AllCells, LLC AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements. Contacts AllCells Wayne Vaz, 510-450-3900 VP, Corporate Development
2011-02-07
AllCells' Research Team Joins Professor Linzhao Cheng In IPSC Technology Joint Effort
Recently, AllCells research team joined Prof. Linzhao Cheng from John Hopkins University in a joint research effort in iPSC technology. The exciting results of the research has been published in Cell Research, Nature Publishing Group journal in January 2011. Download PDF
2011-01-19
Jack Zhai Announced As VP Of Sales Marketing
AllCells LLC, a leading global provider of human hematopoietic primary cells and services, today announced that Jack Zhai has joined the company’s executive leadership team as Vice President, Sales & Marketing. Mr. Zhai received his Ph.D. in Cell and Molecular Biology at UW-Madison. In addition, the company recently strengthened its sales force in North America, product management, and marketing team including applications scientists. View full release.
2011-01-15
Exhibiting At Upcoming Molecular Med Tri-Con 2011 - February 23-25
AllCells will be exhibiting at the upcoming Molecular Med Tri-Con 2011 (February 23-25) meeting taking place at the San Francisco Moscone Convention Center. For more information about the meeting, go to www.triconference.com
2010-12-01
AllCells Granted Tissue Bank License
Emeryville, CA - The company was recently granted a Tissue Bank License by the State of California. View full release.
2010-11-29
AllCells Strenghtens Primary Adult Stem Cell Product Offerings
AllCells, LLC, a leading global provider of human primary cells and related services has announced an expanded range of primary adult stem cell products for in-vitro research use. A total of fifteen (15) new primary stem cell products are now available within the areas of Dental Mesenchymal stem cells, Cord Blood stem cells, Amniotic stem cells, and Placental stem cells. Read more here.
2010-10-04
AllCells Launches Four Different Basal Media Formulations For In-Vitro Research
The company announced that it is introducing four (4) different basal media formulations for cell culture use, including: Dulbecco's Modified Eagles Medium (DMEM) with various amounts of glucose, Iscove's Modification of DMEM Medium (IMDM), and Roswell Park Memorial Institute Medium (RPMI). Read more here.
2010-09-29
Exhibiting At The 52nd Annual ASH Annual Meeting
AllCells will be exhibiting at the upcoming American Society of Hematology Annual Meeting. Read more here.
2010-09-21
AllCells, LLC Named Winner Of The 2010 Biotechnology Standard Of Excellence Award
AllCells, LLC, a leading global provider of human primary cells and related services has announced that the Boston-based Web Marketing Association (WMA) has named AllCells.com winner of the 2010 Biotechnology Standard of Excellence Award. View full release.
2010-09-17
Attending Upcoming ASH Annual Meeting In December
AllCells is pleased to announce we will be attending the American Society of Hematology annual meeting, taking place in Orlando, FL in December. Visit our booth (#1365) for your chance to win a prize! More details will be revealed in the coming months. For more information on the American Society of Hematology, please visit www.hematology.org
2010-06-16
AllCells Enters IPSC And ESC-Based Research Agreement With Johns Hopkins University
AllCells LLC (the “Company”), a leading supplier of primary cell products and related services announces it has entered into a research agreement with Johns Hopkins University (“JHU”) involving the characterization of iPSC and ESC derived human hematopoietic cells. View full release.
2010-06-08
AllCells To Exhibit At The 8th Annual ISSCR Meeting In San Francisco, CA - June 16-19
AllCells will enlighten conference attendees with information about their stem cell products and services at the 8th annual ISSCR meeting. Read more here.
2010-06-01
Currently Hiring For Inside And Outside Account Managers
AllCells is hiring for top notch Inside and Outside Account Managers! Please visit our Careers section for more details.
2010-05-25
Attending Upcoming 2010 ISSCR Annual Meeting In San Francisco, CA
AllCells is pleased to announce our attendance in the 2010 ISSCR conference in San Francisco, CA. During the ISSCR, we will be higlighting our products and services to our stem cell research community. Visit us at booth #317. For more information regarding the ISSCR, please visit www.isscr.org
2010-05-11
Stem Cell Distributor AllCells: Finding A Cure
AllCells, stem cell distributor and progenitor provider, carries cells for blood related disease research. Visit www.allcells.com or call 1-888-535-3444. Read more: AllCells Stem Cell Distributor.
2010-05-07
AllCells Announces Hematopoietic Disease Cells
AllCells is excited to announce Hematopoietic cells from donors with blood related disease including Leukemia, Lymphoma, Myelodysplastic syndrome, Myeloproliferative disease and Multiple Myeloma. These cells allow researchers to understand what causes the disease in these cells and allow them to study how to eradicate the disease. Read more: AllCells announces hematopoietic disease cells for blood related disease research.
2010-04-05
AllCells, LLC Announces Completed Expansion Into New 10,000 sq ft Office/Laboratory Space
EMERYVILLE, Calif.--(BUSINESS WIRE)--AllCells LLC (the “Company”), a leading supplier of primary cell types, today announced it has completed its expansion into 10,000 additional square feet of office and laboratory production space located in Emeryville, California. The newly leased space, adjacent to AllCells’ headquarters, will be used to meet the rapidly growing demand for the Company’s hematopoietic stem/progenitor and other primary cell products used for drug discovery, regenerative medicine, cell-based assay development, and other research applications. View full release.
2010-03-31
Upcoming Exhibit At The 2010 AAI Conference In Baltimore, MD
AllCells is pleased to announce our attendance at the 2010 American Association of Immunologists conference in Baltimore, MD. During the AAI, we will be higlighting our products and services to our cancer research community. We will be exhibit in booth #1203. For more information regarding the AAI, please visit www.aai.org
2010-03-29
Upcoming Exhibit At The 2010 AACR Conference In Washington D.C.
AllCells is pleased to announce our attendance to the 2010 Annual AACR conference in Washington D.C. During the AACR, we will be higlighting our products and services to our cancer research community. We will be exhibit in booth #2038. For more information regarding the AACR, please visit www.aacr.org.
Spacer Middle

Sign-Up for Our eNewsletter


Spacer Middle
News & Events
2014-11-19 | AllCells proudly exhibiting at 56th Annual ASH Meeting in San Francisco, CA Dec 6-9
2014-10-21 | Join AllCells at the AABB 2014 Annual Meeting in Philadelphia, PA Oct 25-28
Spacer Middle